Huiling Tan

机构：Guangzhou University of Chinese Medicine, Ministry of Education of the People's Republic of China, Guangdong Pharmaceutical University · ORCID：0000-0003-4973-0306

发表论文 4 篇 · 总被引 56 次 · h-index 3

代表论文

• Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m6A modification of SIRT3 mRNA (2023 · Journal of Ethnopharmacology · 被引 22)
• The m6A Reader YTHDF1 Promotes Lung Carcinoma Progression via Regulating Ferritin Mediate Ferroptosis in an m6A-Dependent Manner (2023 · Pharmaceuticals · 被引 16)
• BAG3 Alleviates Atherosclerosis by Inhibiting Endothelial-to-Mesenchymal Transition via Autophagy Activation (2022 · Genes · 被引 15)
• Fu Fang Zhen Zhu Tiao Zhi Capsules Protect against Myocardial Ischemia by Inhibiting Cardiomyocyte Pyroptosis (2022 · Evidence-based Complementary and Alternative Medicine · 被引 3)